Clinical Indications and Who May Benefit Based on the preclinical literature and emerging clinical use patterns, BPC-157 is most commonly applied in the following areas: Tendon, ligament, and muscle injuries (sprains, partial tears, chronic tendinopathy) Post-surgical tissue healing and recovery acceleration Inflammatory bowel conditions (Crohns, ulcerative colitis, leaky gut syndromes) NSAID-induced gastric damage notably, BPC-157 counteracts aspirin- and ibuprofen-driven mucosal injury Neuropathy and nerve regeneration protocols Systemic inflammation and autoimmune flares Recovery from alcohol-related liver and gut damage It is also increasingly used as a component in broader peptide therapy protocols alongside BPC-157s companion compounds
Interestingly, a study found that glutathione IV therapy can significantly reduce melanin levels from 272.77 to 243.47 within only weeks of treatment
Also of interest is that GSH supplementation resulted in a reduction of oxidized GSH levels in blood, suggestive of a reduction in levels of oxidative stress
Ren G, Roberts AI, Shi Y
Plant Soil 219(12):2128 Ma X, Geiser-Lee J, Deng Y, Kolmakov A (2010) Interactions between engineered nanoparticles (ENPs) and plants: phytotoxicity, uptake and accumulation
Interestingly, the use of diuretics for treating carpal tunnel syndrome is less widespread but still worth mentioning
